Author:
Gelber R.D.,Cole B.F.,Goldhirsch A.,Rose C.,Fisher B.,Osborne C.K.,Boccardo F.,Gray R.,Gordon N.H.,Bengtsson N-O.,Sevelda P.
Reference31 articles.
1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 relapses and 24 000 deaths among 75 000 women;Lancet,1992
2. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study;Boccardo;J Clin Oncol,1990
3. Adjuvant systemic risk adapted cytotoxic±tamoxifen therapy in women with node positive breast cancer;Kaufmann,1987
4. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis;Goldhirsh;J Clin Oncol,1989
5. Quality adjusted survival analysis;Glasziou;Stat Med,1990
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献